首页> 外文期刊>British Journal of Pharmaceutical Research >Development of Anti-bacterial Ointment from Two Extracts of Curcuma longa L. and Aloe vera L.
【24h】

Development of Anti-bacterial Ointment from Two Extracts of Curcuma longa L. and Aloe vera L.

机译:姜黄和芦荟两种提取物的抗菌药膏研制

获取原文
           

摘要

Aim of this Study: This study aimed to extract, formulate and evaluate an antibacterial ointment from extracts of two Yemeni plants. Methods: The extraction of both Curcuma longa and Aloe vera was performed using alcoholic and hydro-alcoholic solvents, respectively. The in-vitro antibacterial activity of C. longa and A. vera extracts was investigated using well agar diffusion and disc diffusion method against Pseudomonas aeruginosa and Staphylococcus aureus , respectively. Finally, the ointment was prepared from a combination of these two extracts then stability study testing was performed and also the in-vitro activity antibacterial of this ointment against the above bacteria was done. Results: The extracts inhibited the growth of both bacteria with zone of inhibition between 6 mm-14mm at 0.52 mg-20 mg/100 μl. The MIC of C. longa and A. vera extract were 0.25 mg/100 μl and 0.4 mg/100 μl respectively in P. aeruginosa and 0.25 mg/100 μl in S. aureus for both extracts. The prepared ointment showed satisfactory physicochemical results and the antibacterial activity was 20 mm and 7 mm for P. aeruginosa and S. aureus , respectively. The pH was in a proper range (pH 5.2-5.5). The formulation was found to be stable during stability study according to ICH guideline (25 ± 2°C/65 ± 5% RH and 40 ± 2°C/75 ± 5% RH) for one month. The assay test of active ingredient was done using UV -Visible spectrophotometry. Curcumin content was 59.70% to 59.78% in ointment. Aloin assay was 81 to 81.21% in the prepared ointment. Conclusion: These finding showed that the formulated new antibacterial ointment is stable and economic formula and consider as database for further clinical studies in spite of both plants used safely in large doses in traditional medicine.
机译:这项研究的目的:这项研究旨在从两个也门植物的提取物中提取,配制和评估一种抗菌药膏。方法:分别用酒精和水-酒精溶剂提取姜黄和芦荟。采用良好的琼脂扩散法和圆盘扩散法分别研究了铜绿假单胞菌提取物和铜绿假单胞菌提取物对铜绿假单胞菌和金黄色葡萄球菌的体外抗菌活性。最后,由这两种提取物的组合制备软膏,然后进行稳定性研究测试,并且还对该软膏进行了针对上述细菌的体外抗菌活性。结果:提取物在0.52 mg-20 mg / 100μl的6 mm-14mm范围内抑制了两种细菌的​​生长。两种提取物在铜绿假单胞菌和金黄色葡萄球菌中的长假丝酵母和金黄色葡萄球菌提取物的MIC分别为0.25 mg / 100μl和0.4 mg / 100μl。制备的软膏具有令人满意的理化效果,其对铜绿假单胞菌和金黄色葡萄球菌的抗菌活性分别为20 mm和7 mm。 pH在适当范围内(pH 5.2-5.5)。根据ICH准则(25±2°C / 65±5%RH和40±2°C / 75±5%RH),在稳定性研究中发现该制剂稳定1个月。活性成分的测定测试使用紫外可见分光光度法进行。软膏中姜黄素含量为59.70%至59.78%。所制备的软膏中芦荟苷含量为81%至81.21%。结论:这些发现表明所配制的新型抗菌药膏是稳定且经济的配方,尽管这两种植物均已在传统医学中安全地大剂量安全使用,但仍被视为进一步临床研究的数据库。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号